Arch Biopartners Inc. (TSXV:ARCH)
Canada · Delayed Price · Currency is CAD 1.710
-0.040 (-2.29%)
Aug 13, 2025, 3:13 PM EDT
G1 Therapeutics Market Cap
Arch Biopartners has a market cap or net worth of CAD 114.59 million as of August 13, 2025. Its market cap has increased by 6.74% in one year.
Market Cap
114.59M
Enterprise Value
117.32M
Revenue
-242.79K
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.71
Market Cap Chart
Since January 21, 2011, Arch Biopartners's market cap has increased from 33.37M to 114.59M, an increase of 243.36%. That is a compound annual growth rate of 8.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 114.59M | -9.16% |
| Dec 31, 2024 | 126.14M | 36.32% |
| Dec 29, 2023 | 92.53M | -47.32% |
| Dec 30, 2022 | 175.66M | -18.54% |
| Dec 31, 2021 | 215.63M | 145.71% |
| Dec 29, 2020 | 87.76M | 53.80% |
| Dec 26, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 2.28B |
| Curaleaf Holdings | 2.14B |
| Sienna Senior Living | 1.72B |
| dentalcorp Holdings | 1.63B |
| Trulieve Cannabis | 1.51B |
| WELL Health Technologies | 1.24B |
| Cronos Group | 1.22B |
| Extendicare | 1.10B |